Insider Transactions in Q2 2023 at Broadridge Financial Solutions, Inc. (BR)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 26
2023
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
186
+1.84%
|
-
|
|
Jun 26
2023
|
Eileen K Murray Director |
BUY
Grant, award, or other acquisition
|
Direct |
186
+15.38%
|
-
|
|
Jun 26
2023
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
186
+7.01%
|
-
|
|
Jun 26
2023
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
170
+3.04%
|
-
|
|
Jun 02
2023
|
Leslie A Brun Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,396
+16.23%
|
$518,256
$36.35 P/Share
|
|
Jun 01
2023
|
Robert N Duelks Director |
SELL
Payment of exercise price or tax liability
|
Direct |
8,613
-19.37%
|
$1,248,885
$145.78 P/Share
|
|
Jun 01
2023
|
Robert N Duelks Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,841
+19.6%
|
$390,276
$36.35 P/Share
|
|
Jun 01
2023
|
Leslie A Brun Director |
SELL
Open market or private sale
|
Direct |
6,900
-10.33%
|
$1,021,200
$148.98 P/Share
|
|
Jun 01
2023
|
Leslie A Brun Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,866
+2.72%
|
$67,176
$36.35 P/Share
|
|
May 19
2023
|
Laura Matlin CVP, Deputy GC and CCO |
SELL
Open market or private sale
|
Direct |
4,052
-41.03%
|
$619,956
$153.73 P/Share
|
|
May 19
2023
|
Laura Matlin CVP, Deputy GC and CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,725
+32.36%
|
$316,575
$67.32 P/Share
|
|
May 05
2023
|
Robert N Duelks Director |
SELL
Open market or private sale
|
Direct |
1,200
-3.44%
|
$184,800
$154.34 P/Share
|
|
May 05
2023
|
Robert N Duelks Director |
SELL
Bona fide gift
|
Direct |
100
-0.29%
|
-
|
|
May 04
2023
|
Robert F Kalenka Corporate Vice President |
SELL
Open market or private sale
|
Direct |
17,433
-15.12%
|
$2,649,816
$152.63 P/Share
|
|
May 04
2023
|
Robert F Kalenka Corporate Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
17,289
+18.03%
|
$1,659,744
$96.09 P/Share
|
|
May 04
2023
|
Robert Schifellite Corporate SVP |
SELL
Open market or private sale
|
Direct |
15,695
-12.55%
|
$2,385,640
$152.59 P/Share
|
|
May 04
2023
|
Robert Schifellite Corporate SVP |
BUY
Exercise of conversion of derivative security
|
Direct |
12,397
+15.81%
|
$830,599
$67.32 P/Share
|
|
May 04
2023
|
Richard John Stingi Corporate VP and CHRO |
SELL
Open market or private sale
|
Direct |
750
-15.15%
|
$116,250
$155.27 P/Share
|
|
Apr 06
2023
|
Thomas P Carey Corporate VP |
SELL
Payment of exercise price or tax liability
|
Direct |
2,148
-16.65%
|
$298,572
$139.91 P/Share
|
|
Apr 05
2023
|
Leslie A Brun Director |
BUY
Grant, award, or other acquisition
|
Direct |
137
+0.21%
|
-
|
|
Apr 05
2023
|
Pamela L Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.49%
|
-
|
|
Apr 05
2023
|
Robert N Duelks Director |
BUY
Grant, award, or other acquisition
|
Direct |
96
+0.27%
|
-
|
|
Apr 05
2023
|
Melvin L Flowers Director |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.44%
|
-
|
|
Apr 05
2023
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
48
+0.25%
|
-
|
|
Apr 05
2023
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
81
+0.17%
|
-
|
|
Apr 05
2023
|
Eileen K Murray Director |
BUY
Grant, award, or other acquisition
|
Direct |
3
+0.36%
|
-
|
|
Apr 05
2023
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.2%
|
-
|
|
Apr 05
2023
|
Thomas J Perna Director |
BUY
Grant, award, or other acquisition
|
Direct |
96
+0.32%
|
-
|
|
Apr 05
2023
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.24%
|
-
|
|
Apr 03
2023
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
204
+2.06%
|
-
|
|
Apr 03
2023
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
204
+8.24%
|
-
|
|
Apr 03
2023
|
Eileen K Murray Director |
BUY
Grant, award, or other acquisition
|
Direct |
204
+19.65%
|
-
|
|
Apr 03
2023
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
186
+3.43%
|
-
|
|
Apr 01
2023
|
Richard J Daly Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
742
-0.52%
|
$108,332
$146.57 P/Share
|
|
Apr 01
2023
|
Douglas Richard Deschutter Co-President ICS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,202
-3.48%
|
$175,492
$146.57 P/Share
|
|
Apr 01
2023
|
Christopher John Perry President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,950
-6.8%
|
$722,700
$146.57 P/Share
|
|
Apr 01
2023
|
Timothy C Gokey CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,499
-11.04%
|
$2,554,854
$146.57 P/Share
|
|
Apr 01
2023
|
Robert F Kalenka Corporate Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,170
-4.21%
|
$170,820
$146.57 P/Share
|
|
Apr 01
2023
|
Robert Schifellite Corporate SVP |
SELL
Payment of exercise price or tax liability
|
Direct |
4,004
-6.95%
|
$584,584
$146.57 P/Share
|
|
Apr 01
2023
|
Laura Matlin CVP, Deputy GC and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
466
-8.3%
|
$68,036
$146.57 P/Share
|
|
Apr 01
2023
|
Richard John Stingi Corporate VP and CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,681
-13.54%
|
$245,426
$146.57 P/Share
|
|
Apr 01
2023
|
Richard John Stingi Corporate VP and CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,360
+17.02%
|
-
|
|
Apr 01
2023
|
Edmund Reese Corporate VP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
547
-9.63%
|
$79,862
$146.57 P/Share
|